Univariate Survival Analysis
| Characteristic . | N . | Median (y) . | P Value . |
|---|---|---|---|
| β2M (mg/mL) | |||
| <2.7 | 130 | 5.1 | <.0001 |
| ≥2.7 | 318 | 3.3 | |
| PCLI | |||
| <1% | 305 | 4.1 | <.0001 |
| ≥1% | 121 | 2.4 | |
| sIL-6R (ng/mL) | |||
| >270 | 332 | 3.9 | .0005 |
| ≤270 | 115 | 2.6 | |
| CRP (mg/dL) | |||
| <2 | 153 | 3.9 | .0254 |
| ≥2 | 293 | 3.5 | |
| Creatinine (mg/dL) | |||
| <2 | 373 | 3.9 | <.0001 |
| 2-5 | 80 | 2.8 | |
| Albumin (g/dL) | |||
| ≤3 | 98 | 2.8 | .0008 |
| >3 | 350 | 3.9 | |
| Hemoglobin (g/dL) | |||
| ≤10 | 164 | 2.9 | <.0001 |
| >10 | 289 | 4.1 | |
| Calcium (mg/dL) | |||
| <12 | 420 | 3.7 | .0002 |
| ≥12 | 30 | 2.2 | |
| Age (yr) | |||
| <65 | 257 | 3.7 | .0852 |
| ≥65 | 196 | 3.3 | |
| Stage | |||
| I, II | 202 | 4.1 | .0016 |
| III | 251 | 3.1 | |
| Sex | |||
| Male | 276 | 3.5 | .0414 |
| Female | 177 | 4.0 | |
| Bence Jones protein | |||
| <1 g/24 h | 128 | 4.1 | .0434 |
| >1 g/24 h | 122 | 3.5 | |
| Urine light chain | |||
| κ | 212 | 3.7 | .1560 |
| λ | 116 | 3.3 |
| Characteristic . | N . | Median (y) . | P Value . |
|---|---|---|---|
| β2M (mg/mL) | |||
| <2.7 | 130 | 5.1 | <.0001 |
| ≥2.7 | 318 | 3.3 | |
| PCLI | |||
| <1% | 305 | 4.1 | <.0001 |
| ≥1% | 121 | 2.4 | |
| sIL-6R (ng/mL) | |||
| >270 | 332 | 3.9 | .0005 |
| ≤270 | 115 | 2.6 | |
| CRP (mg/dL) | |||
| <2 | 153 | 3.9 | .0254 |
| ≥2 | 293 | 3.5 | |
| Creatinine (mg/dL) | |||
| <2 | 373 | 3.9 | <.0001 |
| 2-5 | 80 | 2.8 | |
| Albumin (g/dL) | |||
| ≤3 | 98 | 2.8 | .0008 |
| >3 | 350 | 3.9 | |
| Hemoglobin (g/dL) | |||
| ≤10 | 164 | 2.9 | <.0001 |
| >10 | 289 | 4.1 | |
| Calcium (mg/dL) | |||
| <12 | 420 | 3.7 | .0002 |
| ≥12 | 30 | 2.2 | |
| Age (yr) | |||
| <65 | 257 | 3.7 | .0852 |
| ≥65 | 196 | 3.3 | |
| Stage | |||
| I, II | 202 | 4.1 | .0016 |
| III | 251 | 3.1 | |
| Sex | |||
| Male | 276 | 3.5 | .0414 |
| Female | 177 | 4.0 | |
| Bence Jones protein | |||
| <1 g/24 h | 128 | 4.1 | .0434 |
| >1 g/24 h | 122 | 3.5 | |
| Urine light chain | |||
| κ | 212 | 3.7 | .1560 |
| λ | 116 | 3.3 |